A Multi-Center Phase 2 Study of Acalabrutinib-Lenalidomide-Rituximab with Real-time MRD Monitoring in Patients with Untreated Mantle Cell Lymphoma
WCM IRB # 1807019439
To learn more about this trial, please visit [ Ссылка ] .
![](https://i.ytimg.com/vi/y2ZmbpKA5KM/maxresdefault.jpg)
A Multi-Center Phase 2 Study of Acalabrutinib-Lenalidomide-Rituximab with Real-time MRD Monitoring in Patients with Untreated Mantle Cell Lymphoma
WCM IRB # 1807019439
To learn more about this trial, please visit [ Ссылка ] .